Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Beneficial effects of pioglitazone, a selective peroxisome proliferator‐activated receptor‐γ agonist in prenatal valproic acid‐induced behavioral and biochemical autistic like features in Wistar rats
Roohi Mirza, Bhupesh Sharma
International Journal of Developmental Neuroscience (2019) Vol. 76, Iss. 1, pp. 6-16
Closed Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

A Systematic Review of the Valproic-Acid-Induced Rodent Model of Autism
Devahuti R. Chaliha, Matthew A. Albrecht, Mauro Vaccarezza, et al.
Developmental Neuroscience (2020) Vol. 42, Iss. 1, pp. 12-48
Open Access | Times Cited: 124
Emerging mechanisms of valproic acid-induced neurotoxic events in autism and its implications for pharmacological treatment
Abdoh Taleb, Wen Lin, Xiang Xu, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 137, pp. 111322-111322
Open Access | Times Cited: 65
Repetitive Restricted Behaviors in Autism Spectrum Disorder: From Mechanism to Development of Therapeutics
Junbin Tian, Xuping Gao, Li Yang
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 58
Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders?
Michele Tufano, Graziano Pinna
Molecules (2020) Vol. 25, Iss. 5, pp. 1062-1062
Open Access | Times Cited: 51
Cannabidiol for the treatment of autism spectrum disorder: hope or hype?
João Francisco Cordeiro Pedrazzi, Frederico Rogério Ferreira, Danyelle Silva-Amaral, et al.
Psychopharmacology (2022) Vol. 239, Iss. 9, pp. 2713-2734
Closed Access | Times Cited: 31
Three Decades of Valproate: A Current Model for Studying Autism Spectrum Disorder
David Zárate-López, Ana Laura Torres-Chávez, Alma Y. Gálvez‐Contreras, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 2, pp. 260-289
Open Access | Times Cited: 19
A selective peroxisome proliferator-activated receptor-γ agonist benefited propionic acid induced autism-like behavioral phenotypes in rats by attenuation of neuroinflammation and oxidative stress
Roohi Mirza, Bhupesh Sharma
Chemico-Biological Interactions (2019) Vol. 311, pp. 108758-108758
Closed Access | Times Cited: 53
Influence of Prenatal Drug Exposure, Maternal Inflammation, and Parental Aging on the Development of Autism Spectrum Disorder
Atsushi Sato, Hiroko Kotajima‐Murakami, Miho Tanaka, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 24
PPARγ and Cognitive Performance
Michele d’Angelo, Vanessa Castelli, Mariano Catanesi, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 20, pp. 5068-5068
Open Access | Times Cited: 42
Attenuation of neurobehavioural abnormalities by papaverine in prenatal valproic acid rat model of ASD
Kanishk Luhach, Giriraj T. Kulkarni, Vijay Pal Singh, et al.
European Journal of Pharmacology (2020) Vol. 890, pp. 173663-173663
Closed Access | Times Cited: 36
Vinpocetine amended prenatal valproic acid induced features of ASD possibly by altering markers of neuronal function, inflammation, and oxidative stress
Kanishk Luhach, Giriraj T. Kulkarni, Vijay Pal Singh, et al.
Autism Research (2021) Vol. 14, Iss. 11, pp. 2270-2286
Closed Access | Times Cited: 31
Mitochondrial morphology is associated with respiratory chain uncoupling in autism spectrum disorder
Richard E. Frye, Loïc Lionnard, Indrapal N. Singh, et al.
Translational Psychiatry (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 29
Probiotics and prebiotics alleviate behavioral deficits, inflammatory response, and gut dysbiosis in prenatal VPA-induced rodent model of autism
Emre Adıgüzel, Betül Çiçek, Gökhan Ünal, et al.
Physiology & Behavior (2022) Vol. 256, pp. 113961-113961
Closed Access | Times Cited: 20
Therapeutic potential of CBD in Autism Spectrum Disorder
João Francisco Cordeiro Pedrazzi, Lucas Hassib, Frederico Rogério Ferreira, et al.
International review of neurobiology (2024), pp. 149-203
Closed Access | Times Cited: 4
Increasing Endocannabinoid Tone Alters Anxiety-Like and Stress Coping Behaviour in Female Rats Prenatally Exposed to Valproic Acid
Aoife M. Thornton, Rachel M. Humphrey, Daniel M. Kerr, et al.
Molecules (2021) Vol. 26, Iss. 12, pp. 3720-3720
Open Access | Times Cited: 21
Adolescent swimming exercise following maternal valproic acid treatment improves cognition and reduces stress-related symptoms in offspring mice: Role of sex and brain cytokines
Ali Barzegari, Hassan Amouzad Mahdirejei, Masoumeh Hanani, et al.
Physiology & Behavior (2023) Vol. 269, pp. 114264-114264
Closed Access | Times Cited: 8
Novel potential of metformin on valproic acid‐induced autism spectrum disorder in rats: involvement of antioxidant defence system
Ismail O. Ishola, Aishat Oyinkansola Balogun, Olufunmilayo O. Adeyemi
Fundamental and Clinical Pharmacology (2020) Vol. 34, Iss. 6, pp. 650-661
Closed Access | Times Cited: 23
Ameliorating effect of pioglitazone on prenatal valproic acid-induced behavioral and neurobiological abnormalities in autism spectrum disorder in rats
Arushi Sandhu, Kajal Rawat, Vipasha Gautam, et al.
Pharmacology Biochemistry and Behavior (2024) Vol. 237, pp. 173721-173721
Closed Access | Times Cited: 2
Unlocking new avenues for neuropsychiatric disease therapy: the emerging potential of Peroxisome proliferator-activated receptors as promising therapeutic targets
Asmita Deka Dey, Ashi Mannan, Sonia Dhiman, et al.
Psychopharmacology (2024) Vol. 241, Iss. 8, pp. 1491-1516
Closed Access | Times Cited: 2
Physiological mediators of prenatal environmental influences in autism spectrum disorder
Richard E. Frye, Janet Cakir, Shannon Rose, et al.
BioEssays (2021) Vol. 43, Iss. 9
Open Access | Times Cited: 17
Efficacy of Ulinastatin and Sulforaphane Alone or in Combination in Rat Model of Streptozotocin Diabetes Induced Vascular Dementia
Poonam Sharma, Prachi Kaushik, Swati Jain, et al.
Clinical Psychopharmacology and Neuroscience (2021) Vol. 19, Iss. 3, pp. 470-489
Open Access | Times Cited: 17
The Attenuating Effect of Beta-Carotene on Streptozotocin Induced Diabetic Vascular Dementia Symptoms in Rats
Khian Giap Lim, Rajavel Varatharajan, Arunachalam Muthuraman
Molecules (2022) Vol. 27, Iss. 13, pp. 4293-4293
Open Access | Times Cited: 11
The Interactions of the 70 kDa Fragment of Cell Adhesion Molecule L1 with Topoisomerase 1, Peroxisome Proliferator-Activated Receptor γ and NADH Dehydrogenase (Ubiquinone) Flavoprotein 2 Are Involved in Gene Expression and Neuronal L1-Dependent Functions
Gabriele Loers, Ralf Kleene, Ute Bork, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2097-2097
Open Access | Times Cited: 6
Behavioral and biochemical investigations to explore the efficacy of quercetin and folacin in experimental diabetes induced vascular endothelium dysfunction and associated dementia in rats
Poonam Sharma, Khushboo Aggarwal, Rajendra Awasthi, et al.
Journal of Basic and Clinical Physiology and Pharmacology (2021) Vol. 34, Iss. 5, pp. 603-615
Closed Access | Times Cited: 15
Repurposing SGLT2 Inhibitors for Neurological Disorders: A Focus on the Autism Spectrum Disorder
Mohammed M. Nakhal, Salahdein Aburuz, Bassem Sadek, et al.
Molecules (2022) Vol. 27, Iss. 21, pp. 7174-7174
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top